News | May 09, 2025
Agilent inaugurates India Solution Center to accelerate innovation
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
30th Lab in Thyrocare’s expanding network to bring advanced, affordable diagnostics in Bihar and beyond
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
Investment demonstrates confidence in America’s commitment to science and innovation
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA modelsfeatured in two peer-reviewed articles
Subscribe To Our Newsletter & Stay Updated
